EXCELMAB
ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients.
EXCELMAB
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Guangzhou, Guangdong, China
Country:
China
Website Url:
http://www.excelmab.com
Status:
Active
Contact:
020-28211020
Total Funding:
10 M CNY
Current Advisors List
Current Employees Featured
Founder
Investors List
Med-Fine Capital
Med-Fine Capital investment in Series A - ExcelMab
Elite Capital
Elite Capital investment in Series A - ExcelMab
CAS Investment Management
CAS Investment Management investment in Series A - ExcelMab
Korea Investment Partners
Korea Investment Partners investment in Series A - ExcelMab
Official Site Inspections
http://www.excelmab.com
- Host name: 103.41.232.115
- IP address: 103.41.232.115
- Location: China
- Latitude: 34.7725
- Longitude: 113.7266
- Timezone: Asia/Shanghai
More informations about "ExcelMab"
广州爱思迈生物医药科技有限公司
广州爱思迈生物医药科技有限公司是一家处于临床研究阶段的国际化生物制药公司，专注于开发新一代肿瘤免疫双特异性抗体药物，主要针对标准治疗失败的肿瘤患者。爱思迈拥有自主研发的双抗 … See details»
ExcelMab - Crunchbase Company Profile & Funding
Organization. ExcelMab . Connect to CRM . Save . Summary. Financials. … See details»
ExcelMab 2025 Company Profile: Valuation, Funding & Investors
ExcelMab General Information Description. Developer of cancer therapeutics designed for immuno-oncology and bispecific antibody drugs. The company's pharmaceutical products aim to treat and … See details»
Excelmab, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 ExcelMab is a biopharmaceutical developer of bispecial antibodies, focusing on the research and development of tumor immunity bispecial antibodies. ... The statistics for drugs in … See details»
ExcelMab Inc. - VentureRadar
ExcelMab Inc. is a clinical stage biotech company that focuses on Immuno-Oncology and develops next-generation bispecific antibody drugs to help cancer patients who have failed standard care … See details»
ExcelMab - Headquarter Location, Corporate Office Address and …
ExcelMab is Drug Discovery in China that focus on pharmaceutical products business. Founded in 2016. They cover business area such as developer, cancer therapeutic, symptom, various kind, … See details»
ExcelMab - Products, Competitors, Financials, Employees, …
ExcelMab is an innovative biopharmaceutical company focused on the research, development, and global commercialization of a new generation of tumor immunotherapy bispecific antibody drugs. … See details»
Excelmab, Inc. (广州爱思迈生物医药科技有限公司) - 药物管线_专利_ …
May 7, 2025 了解Excelmab, Inc. (广州爱思迈生物医药科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的3项临床试验, 27篇新闻和2篇文献，疾病领域:肿瘤，免疫系统疾病，内分 … See details»
Guangzhou ExcelMab Bio-pharmaceutical Technology Co., Ltd.
ExcelMab. Guangzhou ExcelMab Bio-pharmaceutical Technology Co., Ltd. was founded by Returning Dr. Team led by Dr. Zhang Wenjun, Yuansheng Ventures and Yuanxiao Origin in May … See details»
ExcelMab - Contacts, Employees, Board Members, Advisors & Alumni
Organization. ExcelMab . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. ... ExcelMab has 2 current … See details»
Excelmab Snares ￥10M in Series A+ Round, Developing Bispecific ...
Mar 12, 2020 Excelmab was established by Dr. Wenjun Zhang in 2016 in Guangzhou China. With its novel bispecific antibody platform, Excelmab has developed a series of anti-tumor bispecific … See details»
ExcelMab Inc. - VentureRadar
ExcelMab Inc. is a clinical stage biotech company that focuses on Immuno-Oncology and develops next-generation bispecific antibody drugs to help cancer patients who have failed standard care … See details»
EX 101 - Guangzhou Excelmab - AdisInsight - Springer
11 Sep 2023 Guangzhou ExcelMab announces intention to submit BLA of EX 101 for Breast cancer and Gastric cancer in USA and China, in 2025 (Guangzhou ExcelMab pipeline ... If your … See details»
公司资讯 - excelmab.com
Excelmab is currently developing a variety of bispecific antibody drugs based on the ExMab® platform. The two most advanced drugs, EX101 (for breast and stomach cancer) and EX103 (for … See details»
ExcelMab - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Jul 15, 2024 ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. … See details»
ExcelMab - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 12, 2020: Series A - … See details»
ExcelMab - Updates, News, Events, Signals & Triggers - Crunchbase
ExcelMab develops a series of anti-tumor bispecific antibody drugs for cancer patients. See details»
管线推进 - excelmab.com
广州爱思迈生物医药科技有限公司是一家处于临床研究阶段的国际化生物制药公司，专注于开发新一代肿瘤免疫双特异性抗体药物，主要针对标准治疗失败的肿瘤患者。爱思迈拥有自主研发的双抗 … See details»
产品管线 - excelmab.com
广州爱思迈生物医药科技有限公司是一家处于临床研究阶段的国际化生物制药公司，专注于开发新一代肿瘤免疫双特异性抗体药物，主要针对标准治疗失败的肿瘤患者。爱思迈拥有自主研发的双抗 … See details»
ExcelMab HER2/CD3 BsAb Completed First Human Dosing
Nov 25, 2021 EX101 injection is a bispecific antibody drug targeting HER2 and CD3 , developed based on ExMab®, ExcelMab's bispecific antibody platform, for the treatment of HER2-positive … See details»